191 related articles for article (PubMed ID: 29650836)
1. [A Case of Advanced Esophagogastric Junction Cancer Responding to S-1 Neoadjuvant Chemotherapy].
Kuroda J; Aoki H; Kondou N; Sumita T; Itoh K; Agawa S
Gan To Kagaku Ryoho; 2018 Apr; 45(4):688-690. PubMed ID: 29650836
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
Murakami K; Tamura S; Takeno A; Ishida T; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2010-2012. PubMed ID: 28133205
[TBL] [Abstract][Full Text] [Related]
3. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
4. [A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Oohinata R; Iwasaki Y; Oohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2378-80. PubMed ID: 23268083
[TBL] [Abstract][Full Text] [Related]
5. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Heinrich K; Heinemann V; Stintzing S; Müller L; Ettrich TJ; Büchner-Steudel P; Geißler M; Trojan J; Moosmann N; Folprecht G; Schmidt J; Kanzler S; Kullmann F; Moulin JC; Werner J; Angele MK; Probst V; Held S; Schulz C; Boukovala M
Oncol Res Treat; 2024; 47(6):251-261. PubMed ID: 38565089
[TBL] [Abstract][Full Text] [Related]
7. [A patient with advanced gastroesophageal junction cancer responding completely to S-1 monotherapy].
Shimada A; Aga K; Shimada A; Hosaka M; Shimada S; Onishi T; Yamachika D; Seki H; Yasui N; Matsumoto H
Gan To Kagaku Ryoho; 2013 Jan; 40(1):83-5. PubMed ID: 23306924
[TBL] [Abstract][Full Text] [Related]
8. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction.
Hosoda K; Azuma M; Katada C; Ishido K; Niihara M; Ushiku H; Sakuraya M; Washio M; Wada T; Watanabe A; Harada H; Tanabe S; Koizumi W; Yamashita K; Hiki N
Int J Clin Oncol; 2020 Jun; 25(6):1090-1097. PubMed ID: 32124094
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of advanced gastric cancer completely responding to S-1 neoadjuvant chemotherapy].
Komatsu H; Morimoto J; Yamashita Y; Ikeya T; Yamazoe S; Kodai S; Shimizu S; Yamamoto A; Kanazawa A; Inoue T; Tsukamoto T; Ikehara T; Nishiguchi Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2339-41. PubMed ID: 22202375
[TBL] [Abstract][Full Text] [Related]
11. A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report.
Matsuno Y; Kochi M; Fujii M; Kanamori N; Kaiga T; Mihara Y; Funada T; Miyazaki T; Takayama T
World J Surg Oncol; 2012 Jul; 10():133. PubMed ID: 22759597
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient].
Kemmochi A; Inagawa S; Akashi Y; Inagaki Y; Satomi K; Ohkohchi N
Gan To Kagaku Ryoho; 2016 Jan; 43(1):115-9. PubMed ID: 26809538
[TBL] [Abstract][Full Text] [Related]
13. [S-1 chemotherapy for cancer of the gastric tube used for esophageal reconstruction following surgery for esophageal cancer].
Motoyama S; Mori K; Maruyama K; Sato Y; Hayashi K; Usami S; Suzuki H; Ogawa J
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2287-90. PubMed ID: 18079632
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with TS-1].
Takashima T; Kashiwagi K; Sasaki K; Inoue D; Maeda H; Shibuya H; Hirata K
Gan To Kagaku Ryoho; 2004 Jun; 31(6):935-7. PubMed ID: 15222116
[TBL] [Abstract][Full Text] [Related]
15. [A case of gastric cancer in which grade 2 treatment effects were obtained with preoperative two-week S-1 administration].
Yuasa Y; Okitsu H; Goto M; Edagawa H; Mori O; Tani R; Masuda Y; Kuramoto S; Matsumoto D; Tomibayashi A; Hamada Y; Yamashita M; Fujii Y; Itoh K
Gan To Kagaku Ryoho; 2015 May; 42(5):637-40. PubMed ID: 25981663
[TBL] [Abstract][Full Text] [Related]
16. Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy.
Mori S; Kishimoto H; Tauchi K; Higuchi K
Gastric Cancer; 2006; 9(2):136-9. PubMed ID: 16767370
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer responding completely treated with S-1 therapy].
Wakatsuki K; Yoshioka S; Kataoka M; Tonooka T; Kawamoto J; Oeda Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2303-5. PubMed ID: 20037403
[TBL] [Abstract][Full Text] [Related]
18. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].
Nakajima T; Sato T; Kano K; Maezawa Y; Segami K; Fujikawa H; Ikeda K; Yamada T; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1240-1242. PubMed ID: 27760947
[TBL] [Abstract][Full Text] [Related]
19. [A case of residual gastric cancer accompanied by esophageal invasion in which residual lesions were eradicated by half-dose administration of TS-1].
Abe S; Kojima M; Kurihara H; Tamura H; Kitago M; Sasanuma H; Wada M; Ogihara T
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1421-6. PubMed ID: 12214471
[TBL] [Abstract][Full Text] [Related]
20. [A Case of cStage Ⅲ Esophagogastric Junction Adenocarcinoma That Showed pCR to Preoperative Chemotherapy Containing SOX].
Kobayashi T; Kosuga T; Kubota T; Okamoto K; Shoda K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2369-2371. PubMed ID: 30692467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
